Gastroenterology
Volume 132, Issue 3 , Pages 921-930 , March 2007

Mutagenic Effect of Ribavirin on Hepatitis C Nonstructural 5B Quasispecies In Vitro and During Antiviral Therapy

  • Wolf Peter Hofmann

      Affiliations

    • Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
    • ,
  • Andreas Polta

      Affiliations

    • Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
    • ,
  • Eva Herrmann

      Affiliations

    • Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
    • ,
  • Ulrike Mihm

      Affiliations

    • Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
    • ,
  • Bernd Kronenberger

      Affiliations

    • Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
    • ,
  • Tanja Sonntag

      Affiliations

    • Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
    • ,
  • Volker Lohmann

      Affiliations

    • Department of Molecular Virology, University of Heidelberg, Heidelberg, Germany
    • ,
  • Barbara Schönberger

      Affiliations

    • Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
    • ,
  • Stefan Zeuzem

      Affiliations

    • Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
    • ,
  • Christoph Sarrazin

      Affiliations

    • Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
    • Corresponding Author InformationAddress requests for reprints to: Christoph Sarrazin, MD, Department of Internal Medicine II, Saarland University Hospital, Kirrberger Strasse, 66421 Homburg/Saar, Germany. fax: (49) 6841-16-21305.

Received 15 June 2006 ,Accepted 16 November 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the Deutsche Forschungsgemeinschaft (grant KFO129 to E.H., C.S., and S.Z.) and by a young investigator research grant from Saarland University Hospital (1000/T201000076 HOMFOR 06/9 to W.P.H.). For hepatitis C virus replicon system experiments, ribavirin was provided by Schering-Plough Corp (Kenilworth, NJ) and levovirin was provided by Hoffmann-La Roche Ltd, Pharmaceuticals Division (Basel, Switzerland).

PII: S0016-5085(06)02563-7

doi: 10.1053/j.gastro.2006.12.005

Gastroenterology
Volume 132, Issue 3 , Pages 921-930 , March 2007

Article Tools

* Image Usage & Resolution